• 1  Ortega‐Hernandez OD, Shoenfeld Y. Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol 2012;26:61–72. Cross Ref link Pubmed link
  • 2  Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease. Am J Med 1972;52:148–59. Cross Ref link Pubmed link
  • 3  Mier R, Ansell B, Hall MA, et al. Long‐term follow‐up of children with mixed connective tissue disease. Lupus 1996;5:221–6. Cross Ref link Pubmed link
  • 4  Alarcón‐Segoviá D, Cardiel MH. Comparison between three diagnostic criteria for mixed connective tissue disease: study of 593 patients. J Rheumatol 1989;16:328–56. Pubmed link
  • 5  Minkin W, Rabhan N. Mixed connective tissue disease. Arch Dermatol 1976;112:1535–8. Cross Ref link Pubmed link
  • 6  Gunnarsson R, Molberg O, Gilboe IM, et al. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis 2011;70:1047–51. Cross Ref link Pubmed link
  • 7  Mier RJ, Shishov M, Higginns GC, et al. Paediatric onset mixed connective tissue disease. Rheum Dis Clin North Am 2005;31:483–96. Cross Ref link Pubmed link
  • 8  Greidinger EL, Casciola‐Rosen L, Morris SM, et al. Autoantibody recognition of distinctly modified forms of the U1‐70‐kD antigen is associated with different clinical disease manifestations. Arthritis Rheum 2000;43:881–8. Cross Ref link Pubmed link
  • 9  Setty YN, Pittman CB, Mahale AS, et al. Sicca symptoms and anti‐SSA/Ro antibodies are common in mixed connective tissue disease. J Rheumatol 2002;29:487–9. Pubmed link
  • 10  Szodoray P, Hajas A, Kardos L, et al. Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus 2012;21:1412–22. Cross Ref link Pubmed link
  • 11  Parodi A, Nigro A, Rebora A. Anti‐SL‐Ki antibody in a patient with fatal connective tissue overlap disease. Br J Dermatol 1989;121:243–6. Cross Ref link Pubmed link
  • 12  Vegh J, Szodoray P, Kappelmayer J, et al. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary hypertension. Scand J Immunol.2006;64:69–76. Cross Ref link Pubmed link
  • 13  Bodolay E, Bojan F, Szegedi G, et al. Cytotoxic endothelial cell antibodies in mixed connective tissue disease. Immunol Lett 1989;20:163–8. Cross Ref link Pubmed link
  • 14  Winkelmann RK, Carapeto FJ, Jordon RE. Direct immunofluorescence in the diagnosis of scleroderma syndromes. Br J Dermatol 1977;96:231–8. Cross Ref link Pubmed link
  • 15  Black CM, Maddison PJ, Welsh KI, et al. HLA and immunoglobulin allotypes in mixed connective tissue disease. Arthritis Rheum 1988:31:131–4. Cross Ref link Pubmed link
  • 16  Ruuska P, Hameenkorpi R, Forsberg S, et al. Differences in HLA antigens between patients with mixed connective disease and systemic lupus erythematosus. Ann Rheum Dis 1992;51:52–5. Cross Ref link Pubmed link
  • 17  Zandman‐Goddard G, Solomon M, Rosman Z, Peeva E, Shoenfeld Y. Environment and lupus‐related diseases. Lupus 2012;21:241–50. Cross Ref link Pubmed link
  • 18  Hajas A, Sandor J, Csathy L, et al. Vitamin D insufficiency in a large MCTD population. Autoimmun Rev 2011;10:317–24. Cross Ref link Pubmed link
  • 19  McLaughlin JK, Lipworth L, Murphy DK, Walker PS. The safety of silicone gel‐filled breast implants: a review of the epidemiologic evidence. Ann Plast Surg 2007;59:569–80. Cross Ref link Pubmed link
  • 20  Kondo H. Vascular disease in mixed connective tissue disease (MCTD). Intern Med 2001;40:1176. Cross Ref link Pubmed link
  • 21  Nowicka‐Sauer K, Czuszynska Z, Majkowicz M, et al. Neuropsychological assessment in mixed connective tissue disease: comparison with systemic lupus erythematosus. Lupus 2012;21(9):927–33. Cross Ref link Pubmed link
  • 22  Pope JE. Other manifestations of mixed connective tissue disease. Rheum Dis Clin North Am.2005;31:519–33. Cross Ref link Pubmed link
  • 23  Poullin P, Lefevre P, Durand JM. Mixed connective tissue disease with haemolytic anemia and severe thrombocytopenia due to thrombotic thrombocytopenic purpura. Am J Hematol 1999; 61:275. Cross Ref link Pubmed link
  • 24  Oh YB, Jun JB, Kim CK, et al. Mixed connective tissue disease associated with skin defects of livedoid vasculitis. Clin Rheumatol 2000;19:381–4. Cross Ref link Pubmed link
  • 25  Lee JK, Jung SS, Kim TH, et al. Coexistence of ankylosing spondylitis and mixed connective tissue disease in a single patient. Clin Exp Rheumatoid 1999;17:63.
  • 26  Makita N, Katori H, Takemoto F, et al. A case of mixed connective tissue disease (MCTD) complicated with MPO‐ANCA‐related necrotising glomerulonephritis. Clin Nephrol 2000;54:164–8. Pubmed link
  • 27  Black KA, Zilko PJ, Dawkins RL, et al. Cancer in connective tissue disease. Arthritis Rheum 1982;25:1130–3. Cross Ref link Pubmed link
  • 28  Lundberg IE. The prognosis of mixed connective tissue disease. Rheum Clin North Am.2005;31:535–47. Cross Ref link
  • 29  Bodoly E, Csiki Z, Ben T, et al. Five year follow up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol.2003;21:313–20. Pubmed link
  • 30  Gendi NS, Welsh KI, Van‐Venrooij WJ, et al. HLA type as a predictor of mixed connective tissue disease differentiation: 10 year clinical and immunogenetic follow‐up of 46 patients. Arthritis Rheum 1995;38:259–66. Cross Ref link Pubmed link
  • 31  Konstantinov KN, Harris AA, Barry M, Murata GH, Tzamaloukas AH. Sustained remission of antineutrophil cytoplasmic antibody‐mediated glomerulonephritis and nephrotic syndrome in mixed connective tissue disease. J Clin Med Res 2013;5(4):316–21. Pubmed link
  • 32  Jovancevic B, Lindholm C, Pullerits R. Anti B‐cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long‐term follow‐up and review of the literature. Lupus 2013;22(7):664–74. Cross Ref link Pubmed link
  • 33  Seguchi M, Soejima Y, Tateishi A, Iida H, et al. Mixed connective tissue disease with multiple organ damage: successful treatment with plasmapheresis. Intern Med 2000;39:1119–22. Cross Ref link Pubmed link
  • 34  Poullin P, Lefevre P, Durand JM. Mixed connective tissue disease with hemolytic anemia and severe thrombocytopenia due to thrombotic thrombocytopenic purpura. Am J Haematol 1999;61:275. Cross Ref link